UK funded research on diseases that are a global threat must be made openly available, Cameron tells G7 summitBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h3217 (Published 12 June 2015) Cite this as: BMJ 2015;350:h3217
- Jacqui Wise
The United Kingdom may become the first country in the world to require full transparency of government funded clinical trials on diseases that threaten global security.
The prime minister, David Cameron, told the G7 summit in Germany that the world must be far better prepared for the next Ebola-type virus. He said that, from now on, any UK funded research on diseases that are a threat to global health security will be made openly available and that the UK will look to develop an international agreement that would see the publication of results from all clinical trials of vaccines for relevant diseases.
The commitment relates to research on diseases such as the Ebola …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial